• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series.氨磺必利增强氯氮平治疗氯氮平抵抗性精神分裂症：病例系列
Can J Hosp Pharm. 2022 Jul 4;75(3):234-238. doi: 10.4212/cjhp.3178. eCollection 2022 Summer.
2
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.氨磺必利增效治疗改善氯氮平难治性精神分裂症患者的认知功能和精神病理学：一项 12 周随机、双盲、安慰剂对照试验。
Mil Med Res. 2022 Oct 18;9(1):59. doi: 10.1186/s40779-022-00420-0.
3
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.氨磺必利增效氯氮平治疗精神分裂症无效患者（AMICUS）：一项双盲、安慰剂对照、随机临床试验，评估临床疗效和成本效益。
Health Technol Assess. 2017 Sep;21(49):1-56. doi: 10.3310/hta21490.
4
Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.氯氮平-氨磺必利与氯氮平-喹硫平联合用药治疗对氯氮平部分反应的精神分裂症患者的比较：一项单盲随机研究。
Adv Ther. 2007 Jan-Feb;24(1):1-13. doi: 10.1007/BF02849987.
5
Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.氯氮平联合氨磺必利治疗：英国一家高度戒备医院中难治性暴力型精神分裂症患者的有效治疗策略
CNS Spectr. 2014 Oct;19(5):403-10. doi: 10.1017/S1092852913000874. Epub 2013 Nov 28.
6
Practical issues with amisulpride in the management of patients with schizophrenia.氨磺必利治疗精神分裂症患者时的实际问题
Clin Drug Investig. 2008;28(8):465-77. doi: 10.2165/00044011-200828080-00001.
7
Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.氨磺必利治疗精神分裂症患者氯氮平引起的唾液分泌过多：一项随机、双盲、安慰剂对照的交叉研究。
Int Clin Psychopharmacol. 2006 Mar;21(2):99-103. doi: 10.1097/01.yic.0000188216.92408.69.
8
Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.氨磺必利对氯氮平部分反应或无反应的精神分裂症患者的增效作用。一项随机、双盲、安慰剂对照试验。
Pharmacopsychiatry. 2008 Jan;41(1):24-8. doi: 10.1055/s-2007-993209.
9
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.氨磺必利增强氯氮平疗效：一项针对对氯氮平部分反应的精神分裂症患者的开放性非随机研究。
Acta Psychiatr Scand. 2004 Oct;110(4):292-8. doi: 10.1111/j.1600-0447.2004.00356.x.
10
Augmenting amisulpride with clozapine had led to unmasking of akathisia.用氯氮平增强阿立哌唑的疗效导致了静坐不能的暴露。
Ind Psychiatry J. 2012 Jul;21(2):152-4. doi: 10.4103/0972-6748.119638.

本文引用的文献

1
Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.抗精神病药物的使用与女性精神分裂症患者乳腺癌风险：芬兰全国性巢式病例对照研究。
Lancet Psychiatry. 2021 Oct;8(10):883-891. doi: 10.1016/S2215-0366(21)00241-8. Epub 2021 Aug 30.
2
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.美国精神病学协会《精神分裂症患者治疗实践指南》。
Am J Psychiatry. 2020 Sep 1;177(9):868-872. doi: 10.1176/appi.ajp.2020.177901.
3
Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.氯氮平联合治疗与增效策略在精神分裂症患者中的应用——精神病治疗反应和抵抗（TRRIP）工作组的国际专家调查建议。
Schizophr Bull. 2020 Dec 1;46(6):1459-1470. doi: 10.1093/schbul/sbaa060.
4
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.难治性精神分裂症的神经生物学：抗精神病药物耐药性的途径及未来研究路线图。
NPJ Schizophr. 2020 Jan 7;6(1):1. doi: 10.1038/s41537-019-0090-z.
5
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial.氨磺必利增强氯氮平治疗难治性精神分裂症：一项双盲、安慰剂对照试验。
Ther Adv Psychopharmacol. 2018 Jul;8(7):185-197. doi: 10.1177/2045125318762365. Epub 2018 Mar 8.
6
Guidelines for the Pharmacotherapy of Schizophrenia in Adults.成人精神分裂症的药物治疗指南。
Can J Psychiatry. 2017 Sep;62(9):604-616. doi: 10.1177/0706743717720448. Epub 2017 Jul 13.
7
Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis.氯氮平治疗难治性精神分裂症的反应率：系统评价和荟萃分析的数据。
Can J Psychiatry. 2017 Nov;62(11):772-777. doi: 10.1177/0706743717718167. Epub 2017 Jun 28.
8
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.难治性精神分裂症：精神病治疗反应与抵抗（TRRIP）工作组关于诊断和术语的共识指南
Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503. Epub 2016 Dec 6.
9
The usefulness of rating scales in patients with schizophrenia.评定量表在精神分裂症患者中的效用。
Acta Psychiatr Scand. 2016 Jun;133(6):435. doi: 10.1111/acps.12588.
10
Is the PANSS used correctly? a systematic review.PANSS 使用是否正确？系统评价。
BMC Psychiatry. 2011 Jul 18;11:113. doi: 10.1186/1471-244X-11-113.

Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series.

作者信息

Poonia Sukhpreet, Sharaf Mazen, Procyshyn Ric M, White Randal, Rafizadeh Reza

机构信息

, BSc(Pharm), RPh, is a Clinical Pharmacist Tertiary Mental Health with Lower Mainland Pharmacy Services, Vancouver, British Columbia.

, BSc(Pharm), ACPR, RPh, is a Clinical Pharmacist with the BC Psychosis Program, Lower Mainland Pharmacy Services, Vancouver, British Columbia.

出版信息

Can J Hosp Pharm. 2022 Jul 4;75(3):234-238. doi: 10.4212/cjhp.3178. eCollection 2022 Summer.

DOI:10.4212/cjhp.3178
PMID:35847467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9245404/
Abstract
摘要